Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,326 GBX | +0.51% | +1.22% | +16.08% |
08/05 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
08/05 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.11% | 238B | |
+34.26% | 698B | |
+26.51% | 568B | |
-4.58% | 358B | |
+18.80% | 328B | |
+3.81% | 283B | |
+6.68% | 203B | |
-9.08% | 198B | |
+6.89% | 165B | |
-4.79% | 160B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca's Soliris Approved in China for Treatment of Neuromyelitis Optica Spectrum Disorder